If you have chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) or you…
adminMay 25, 2017
A small study suggests that pembrolizumab may provide lasting remissions in some patients with NK-cell…
adminApril 4, 2017
New targeted treatment now available for Canadians living with the most common form of slow-growing, non-Hodgkin's…
adminFebruary 13, 2017
The BCCA Provincial Systemic Therapy Program approves Bendamustine With Rituximab for Previously Untreated CLL or…
adminJanuary 13, 2017
On September 29, 2016, the pCODR Expert Review Committee (pERC) issued a final recommendation for…
adminDecember 16, 2016
On November 3, 2016, the pCODR Expert Review Committee (pERC) issued a final recommendation for…
adminDecember 16, 2016
On November 3, 2016, the pCODR Expert Review Committee (pERC) issued a final recommendation for…
adminDecember 16, 2016
On July 19, 2016, the pCODR Expert Review Committee (pERC) issued a final recommendation for…
adminDecember 16, 2016
Health Canada has issued a Notice of Compliance with Conditions (NOC/c) for VENCLEXTA™ (venetoclax), a…
adminDecember 16, 2016
